American International Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-57,804
Closed -$1.57M – 3973
2016
Q1
$1.57M Sell
57,804
-4,266
-7% -$114K 0.01% 1224
2015
Q4
$1.8M Buy
62,070
+4,470
+8% +$124K 0.01% 1157
2015
Q3
$1.56M Buy
57,600
+32,456
+129% +$919K 0.01% 1207
2015
Q2
$688K Sell
25,144
-8,970
-26% -$252K ﹤0.01% 1893
2015
Q1
$911K Buy
34,114
+3,082
+10% +$71K ﹤0.01% 1685
2014
Q4
$657K Sell
31,032
-9,958
-24% -$222K ﹤0.01% 1905
2014
Q3
$976K Sell
40,990
-7,684
-16% -$177K ﹤0.01% 1581
2014
Q2
$1.12M Sell
48,674
-690
-1% -$15.2K 0.01% 1497
2014
Q1
$1.13M Buy
49,364
+9,694
+24% +$207K 0.01% 1434
2013
Q4
$733K Buy
39,670
+5,100
+15% +$88.9K ﹤0.01% 1719
2013
Q3
$585K Buy
34,570
+8,480
+33% +$143K ﹤0.01% 1836
2013
Q2
$404K Buy
+26,090
New +$434K ﹤0.01% 2012

Other funds holding NVO

American International Group's NVO Position: Q2 2016 in Review

American International Group sold out of Novo Nordisk (NVO) in Q2 2016, closing a stake of 57,804 shares — an estimated $1.57M sold.

American International Group first reported a position in NVO in Q2 2013 and held it in 12 quarters. The position peaked at $1.8M in Q4 2015. 530 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

  • American International Group reported no remaining Novo Nordisk position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 57,804 Novo Nordisk shares in Q2 2016, an estimated $1.57M.
  • American International Group first reported a position in Novo Nordisk in Q2 2013 and held it in 12 quarters.
  • American International Group's Novo Nordisk position peaked at $1.8M in Q4 2015.
  • 530 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.